(Q39475594)

English

Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study

scientific article published on May 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

allergic rhinitis

1 reference

based on heuristic

inferred from title

perennial allergic rhinitis

1 reference

based on heuristic

inferred from title

author name string

R. H. Kobayashi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

W. N. Beaucher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

J. W. Koepke

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

A. Luskin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

J. H. Ransom

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

J. P. Rosen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

M. J. Sullivan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

V. B. Alderfer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

B. Simpson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

J. A. Smith

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585854

25 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585854

25 May 2024

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0149291895801154?httpAccept=text/xml

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

https://api.elsevier.com/content/article/PII:0149291895801154?httpAccept=text/plain

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

503-513

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Corticosteroids in the management of upper respiratory allergy: the emerging role of steroid nasal sprays

1

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Topical intranasal corticosteroid therapy in rhinitis

3

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis

4

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis

5

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine

6

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study

7

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis

8

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis

9

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis

11

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis

12

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis

13

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis

15

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study

18

1 reference

10.1016/0149-2918(95)80115-4

https://api.crossref.org/works/10.1016/0149-2918(95)80115-4

25 May 2024

Identifiers

10.1016/0149-2918(95)80115-4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39475594&oldid=2164234703"